|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/33 | (2013.01) |
| C07K 14/33 | (2006.01) | ||
| A61K 38/48 | (2006.01) | ||
| C07K2319/55 | (2013.01) | ||
| C12N 5/00 | (2006.01) | ||
| A61K 38/00 | (2013.01) | ||
| C12N 9/52 | (2013.01) | ||
| C12Y 304/24069 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 1/14 | (2018.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 13/10 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 17/06 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/04 | (2018.01) | ||
| A61P 25/14 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 7/00 | (2018.01) |
| (11) | Patento numeris | 3481852 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17742898.4 |
| Europos patento paraiškos padavimo data | 2017-07-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-05-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-12-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/041255 |
| Data | 2017-07-07 |
| (87) | Numeris | WO 2018/009903 |
| Data | 2018-01-11 |
| (30) | Numeris | Data | Šalis |
| 201662360239 P | 2016-07-08 | US |
| (72) |
STENMARK, Paul , SE
DONG, Min , US
ZHANG, Sicai , US
|
| (73) |
Children's Medical Center Corporation ,
55 Shattuck Street, Boston, MA 02115,
US
Stenmark, Paul , Svantearrheniusvag 16c, 10691 Stockholm, SE |
| (54) | A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES |
| A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES |